Effect of nasal continuous positive airway pressure on methacholine-induced bronchoconstriction

Horng Chyuan Lin, Chun Hua Wang, Cheng Ta Yang, Tung Jung Huang, Chih Teng Yu, Wen Bin Shieh, Han Pin Kuo

研究成果: 雜誌貢獻文章同行評審

26 引文 斯高帕斯(Scopus)


Bronchial hyper-responsiveness is a cardinal feature of asthma. To determine whether nasal continuous positive airway pressure (NCPAP) influences airway smooth muscle in response to exogenous stimuli, we examined the effect of NCPAP on aerosolized methacholine-induced bronchoconstriction in 16 stable asthmatic patients. The dose-response curve for each subject was measured by a log transformation and linear regression analysis as well as a formula fitted to the data points to obtain values for a (slope) and b (position). The PD20FEV1 significantly increased in patients receiving 8 cmH2O of NCPAP by one doubling dose compared with that in patients using sham pressure. NCPAP shifted the dose-response curves to be flatter, deviated upwards and to the right. The coefficient a, indicating bronchial reactivity, was significantly lower in patients receiving NCPAP. The coefficient b, indicating the bronchial sensitive threshold, was higher after applying NCPAP. In contrast, coefficients a and b did not change in subjects with sham pressure. NCPAP also significantly enhanced the bronchodilator effect of inhaled salbutamol in response to methacholine-induced bronchoconstriction. In summary, we have shown that NCPAP therapy improves bronchial smooth reactivity with an increase in PD20FEV1 and a reduction in the bronchial reactivity and bronchial sensitivity. Therefore, NCPAP may provide an adjuvant therapy in patients with acute bronchial asthma.
頁(從 - 到)121-128
期刊Respiratory Medicine
出版狀態已發佈 - 1月 1 1995

ASJC Scopus subject areas

  • 肺和呼吸系統醫學


深入研究「Effect of nasal continuous positive airway pressure on methacholine-induced bronchoconstriction」主題。共同形成了獨特的指紋。